Have an Account?

Email address should not be empty!

Email address should not be empty!

Forgot your password?

Close

First Name should not be empty!

Last Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Error message here!

Back to log-in

Close

Rallis India reports record FY26 EBITDA as crop care, seeds businesses drive growth

Tata Group agro-sciences company posts 9 per cent revenue growth to Rs 2,897 crore; margin expansion reflects operational discipline and product momentum

Rallis India Ltd., the Tata Group-backed agro-sciences company, reported a strong financial performance for FY26, delivering its highest-ever EBITDA alongside steady revenue growth driven by robust demand across crop care, seeds and export businesses.

The company posted revenue of Rs 2,897 crore for the financial year ended March 31, 2026, marking a 9 per cent increase over the previous year. EBITDA rose to a record Rs 362 crore, with EBITDA margins improving to 12.5 per cent, underscoring gains from operational efficiencies, portfolio optimisation and disciplined execution.

Profit after tax for the year stood at Rs 184 crore.

For the fourth quarter, revenue grew 6 per cent year-on-year to Rs 456 crore, supported by 5 per cent volume growth and 1 per cent price growth.

“FY26 has been a year of resilient growth and disciplined execution for Rallis India,” said Dr. Gyanendra Shukla, Managing Director & CEO, Rallis India Ltd. “We delivered our highest-ever EBITDA while continuing to strengthen our core businesses, expand our product portfolio and invest in innovation-led growth opportunities.”

Growth Across Core Segments

The Crop Care business recorded 8 per cent growth during the year, supported by healthy traction in domestic formulations and improved market penetration. Within this segment, the domestic formulations business registered 5 per cent growth.

The company’s B2B exports business, including Custom Synthesis Manufacturing (CSM), grew 17 per cent, aided by stronger global demand and improved customer engagement.

Rallis India’s Soil and Plant Health (SPH) segment also delivered an 8 per cent increase in revenue, reflecting growing farmer adoption of sustainable and productivity-enhancing solutions.

The Seeds business emerged as another key growth driver, posting 15 per cent growth during FY26, supported by improved performance in cotton and field crops.

In Q4 FY26, the Crop Care business grew 5 per cent, with the B2C segment delivering strong 15 per cent growth, partially offset by a 7 per cent decline in the B2B business. The Seeds business recorded robust quarterly growth of 23 per cent.

Product Innovation and Operational Strength

During the quarter, Rallis India launched two new insecticide products and introduced two new offerings in its seeds portfolio, reinforcing its focus on innovation and farmer-centric solutions.

The company also achieved its highest-ever production levels for select products during the year, reflecting manufacturing efficiencies and enhanced operational capabilities.

Management highlighted continued investments in digital initiatives aimed at improving farmer engagement, market access and operational agility.

Strategic Focus on Sustainable Growth

Rallis India said it remains focused on strengthening its position in the domestic agrochemicals market while expanding its export footprint through differentiated products and strategic partnerships.

The company continues to prioritise research-led innovation, sustainable agricultural practices and technology-driven solutions to address evolving farmer needs and changing climate conditions.

“With strong fundamentals, a diversified portfolio and continued investments in innovation, we are well-positioned to build long-term value for all stakeholders,” Dr. Shukla added.

Leave a Comment

Newsletter

Stay connected with us.